CoChat

Surface‐active phospholipid: a Pandora’s box of clinical applications. Part II. Barrier and lubricating properties

Hills, B. A. · 2002 · Internal Medicine Journal
Cited by 126

The DOI matches its Crossref record.

Abstract

In Part I, it was described how their configuration renders phospholipid molecules surface active and capable of acting at interfaces in addition to the ­liquid−air interface to which conventional theory has hitherto confined the study of ‘surfactant’ in the lung. Surface‐active phospholipid (SAPL) appears no different to comparable surfactants studied in the physical sciences for the highly desirable properties that their adsorption (reversible binding) can impart to solid surfaces. In Part II, these properties are considered in sites where there is no air. Highly desirable properties include boundary lubrication (lubricity), release (antistick) and the ability of the strongly adsorbed and strongly cohesive SAPL linings to act as barriers against abrasion, corrosion and, possibly, against invasion by microorganisms. As the ‘sealant’, it could be the true barrier rather than the cells providing its mechanical support. Evidence is reviewed for SAPL providing the gastric mucosal barrier to acid in the stomach and preventing the digestion of Helicobacter pylori until that barrier is broken by bile in the duo­denum, where H. pylori cause ulcers. The concept that SAPL provides effortless sliding of many tissues, including pleura, pericardium and peritoneum is reviewed. Particular attention is paid to the load‐bearing joints, where a deficiency has been associated with osteoarthritis. The ability of the same SAPL lining to perform multiple roles is discussed in relation to the peritoneum, where it could provide the lubricant/release agent preventing surgical adhesions, while imparting semipermeability to ‘the membrane’ vital for peritoneal dialysis. In each site, the prophyl­actic use of exogenous SAPL is discussed for its potential clinical applications. (Intern Med J 2002; 32: 242−251)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1445-5994.2002.00201.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. McCutchen CW, 1978, The Joints and Synovial Fluid, 437
  2. Hardy WB, 1935, Collected Papers
  3. Hills BA, 1988, The Biology of Surfactant
  4. 10.1046/j.1444-0903.2001.00200.x · DOI · Paper page
  5. Hills BA, 1992, Graphite‐like lubrication of mesothelium by pleural surfactant, JAppl Physiol, 73, 1034, 10.1152/jappl.1992.73.3.1034 · doi:10.1152/jappl.1992.73.3.1034
  6. Hills BA, 1995, Remarkable anti‐wear properties of joint surfactant, AnnBiomed Eng, 23, 112
  7. 10.1007/BF02584258 · DOI
  8. Hering EA, 1960, Congenital deficiency of the pericardium, J Thorac Cardiovasc Surg, 40, 49, 10.1016/S0022-5223(19)32645-5 · doi:10.1016/s0022-5223(19)32645-5
  9. 10.1016/S0002-9378(16)33077-0 · doi:10.1016/s0002-9378(16)33077-0
  10. 10.1016/0002-9378(84)90612-4 · doi:10.1016/0002-9378(84)90612-4
  11. Charnley J, 1959, Proceedings of Imeche Conference on Biomechanics., 12
  12. 10.1016/S0021-9258(19)69297-5 · DOI · Paper page
  13. Hills BA, 1989, Oligolamellar lubrication of joints by surface active phospholipid, J Rheumatol, 16, 82
  14. 10.1093/rheumatology/37.1.21 · DOI · Paper page
  15. 10.1093/rheumatology/37.2.143 · DOI
  16. Rabinowitz JL, 1984, Lipid composition of the tissues of human knee joints. II. Synovial fluid in trauma, Clin Orthop, 190, 292, 10.1097/00003086-198411000-00052 · doi:10.1097/00003086-198411000-00052
  17. 10.1093/rheumatology/38.10.1020 · DOI
  18. 10.1093/rheumatology/37.6.649 · doi:10.1093/rheumatology/37.6.649
  19. 10.1093/rheumatology/35.9.821 · DOI
  20. 10.1016/S0043-1648(96)07482-0 · DOI
  21. 10.1093/rheumatology/37.5.532 · DOI
  22. Ghosh P, 1988, Baillière’sClinical Rheumatology, 310
  23. Coman DR, 1961, Adhesiveness and stickiness: two independent properties of the cell surface, Cancer Res, 21, 1436
  24. Hills BA, 1985, Arrest of metastatic cells. Agents promoting and inhibiting non‐specificadhesion by fibronectin, Anticancer Res, 5, 287
  25. Ar’Rajab A, 1995, Exogenous phospholipid reduces postoperative peritoneal adhesions in rats, Eur J Surg, 161, 341
  26. 10.1046/j.1440-1622.1999.01578.x · DOI
  27. Nathan CC, 1972, Corrosion Inhibitors, 71
  28. Werther JL, 2000, The gastric mucosal barrier, Mt Sinai J Med, 67, 41
  29. Davenport HW, 1983, The Gastric Mucosal Barrier ‐ a Swan Song
  30. 10.5694/j.1326-5377.1990.tb136796.x · DOI
  31. Hills BA, 1983, Gastric mucosal barrier: hydrophobic lining to the lumen of the stomach, AmJ Physiol, 244, 561
  32. 10.1016/0016-5085(90)90826-M · DOI
  33. 10.1016/0005-2760(94)00221-J · DOI
  34. 10.1016/0016-5085(86)90627-X · DOI
  35. 10.1136/gut.34.5.588 · doi:10.1136/gut.34.5.588
  36. Brown KA, 1986, The Blood−Brain Barrier in Health and Disease, 188
  37. Hills BA, 1989, A physical identity for the blood‐brain barrier, Proc RSoc NSW, 122, 13
  38. Bradbury M, 1979, The Concept of a Blood−Brain Barrier
  39. 10.1016/0306-9877(90)90142-2 · DOI
  40. Hills BA, 2000, Role of surfactant in peritoneal dialysis, Perit DialInt, 20, 503, 10.1177/089686080002000505 · DOI
  41. 10.1159/000184022 · doi:10.1159/000184022

Cited by

See all 126

Metadata

Authors
Hills, B. A.
Venue
Internal Medicine Journal
Publisher
Wiley
Published
2002-05
Volume
32
Issue
5-6
Pages
242-251
ISSN
  • 1444-0903 (ISSN-L)
  • 1445-5994
OpenAlex
W2065562490
Cited by
126
References
0
FWCI
6.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Surface‐active phospholipid: a Pandora’s box of clinical applications. Part II. Barrier and lubricating properties. https://app.cochat.ai/papers/10.1046/j.1445-5994.2002.00201.x
The paper
Hills, B. A. (2002). Surface‐active phospholipid: a Pandora’s box of clinical applications. Part II. Barrier and lubricating properties. Internal Medicine Journal. https://doi.org/10.1046/j.1445-5994.2002.00201.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.